Hedge Fund - Suvretta Capital Management
Ultragenyx Pharmaceutical Inc. (RARE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $46,437,000 | 0.95% | 2,019,000 | $32.89 |
| 2 | 2025 - Q3 (2025-09-30) | $60,731,520 | 1.55% | 2,019,000 | $29.99 |
| 3 | 2025 - Q2 (2025-06-30) | $82,828,080 | 2.5% | 2,278,000 | $36.05 |
| 4 | 2025 - Q1 (2025-03-31) | $73,307,145 | 2.72% | 2,024,500 | $41.60 |
| 5 | 2024 - Q4 (2024-12-31) | $48,435,780 | 1.65% | 1,151,314 | $49.61 |
| 6 | 2024 - Q3 (2024-09-30) | $63,955,493 | 2.04% | 1,151,314 | $50.94 |
| 7 | 2024 - Q2 (2024-06-30) | $84,724,609 | 3.11% | 2,061,426 | $42.70 |
| 8 | 2024 - Q1 (2024-03-31) | $78,290,306 | 2.9% | 1,676,811 | $47.17 |
| 9 | 2023 - Q4 (2023-12-31) | $101,679,953 | 4.59% | 2,126,306 | $38.77 |
| 10 | 2023 - Q3 (2023-09-30) | $24,222,713 | 1.3% | 679,459 | $39.62 |
| 11 | 2023 - Q2 (2023-06-30) | $24,978,472 | 1.33% | 541,480 | $46.38 |
| 12 | 2023 - Q1 (2023-03-31) | $24,720,848 | 1.04% | 616,480 | $42.91 |
| 13 | 2022 - Q4 (2022-12-31) | $37,859,532 | 1.59% | 817,171 | $39.33 |
| 14 | 2022 - Q3 (2022-09-30) | $3,683,000 | 0.15% | 88,940 | $51.39 |
| 15 | 2022 - Q2 (2022-06-30) | $20,793,000 | 0.79% | 348,519 | $61.54 |
| 16 | 2022 - Q1 (2022-03-31) | $38,133,000 | 1.16% | 525,100 | $69.58 |
| 17 | 2021 - Q4 (2021-12-31) | $40,804,000 | 0.79% | 485,242 | $81.37 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center